The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 11,962 | 1,161,375 | SH | SOLE | 1,161,375 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 6,125 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 628 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 9,263 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| ALTIMMUNE INC | COM NEW | 02155H200 | 2,640 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 421 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 4,722 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 20,062 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 8,102 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 4,158 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 6,698 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 1,191 | 4,200 | SH | SOLE | 4,200 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 281 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 247 | 4,500 | SH | SOLE | 4,500 | 0 | 0 | ||
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 14,689 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 7,994 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 1,445 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 8,472 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| GRAYBUG VISION INC | COM SHS | 38942Q103 | 953 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| IMMUNIC INC | COM | 4525EP101 | 4,921 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
| IMV INC | COM | 44974L103 | 1,443 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 18,475 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 18,929 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 5,640 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,407 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 6,894 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| MILLENDO THERAPEUTICS INC | COM | 60040X103 | 1,508 | 925,000 | SH | SOLE | 925,000 | 0 | 0 | ||
| MODERNA INC | COM | 60770K107 | 708 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 19,551 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 9,963 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| MYOVANT SCIENCES LTD | COM | G637AM102 | 3,513 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| NEXTCURE INC | COM | 65343E108 | 3,520 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 3,703 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 9,144 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 2,923 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 2,064 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 6,273 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 9,128 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 778 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| SURFACE ONCOLOGY INC | COM | 86877M209 | 6,900 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 5,352 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 27,710 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 5,027 | 805,556 | SH | SOLE | 805,556 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 3,608 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 27,858 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
| SPDR SER TR | S&P BIOTECH | 78464A870 | 22,397 | 201,000 | SH | Put | SOLE | 201,000 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,598 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||